Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Invivyd Inc (IVVD)
Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 169,577
  • Shares Outstanding, K 110,115
  • Annual Sales, $ 0 K
  • Annual Income, $ -241,320 K
  • 60-Month Beta -0.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.68
Trade IVVD with:

Options Overview Details

View History
  • Implied Volatility 215.84% ( +113.66%)
  • Historical Volatility 52.26%
  • IV Percentile 83%
  • IV Rank 48.49%
  • IV High 434.63% on 07/11/23
  • IV Low 9.88% on 12/06/22
  • Put/Call Vol Ratio 999.99
  • Today's Volume 30
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,112
  • Open Int (30-Day) 891

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.44
  • Number of Estimates 3
  • High Estimate -0.37
  • Low Estimate -0.56
  • Prior Year -0.41
  • Growth Rate Est. (year over year) -7.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +12.41%
on 11/13/23
1.6300 -5.52%
on 11/08/23
+0.0700 (+4.76%)
since 11/01/23
3-Month
1.3700 +12.41%
on 11/13/23
1.9900 -22.61%
on 09/13/23
-0.2900 (-15.85%)
since 09/01/23
52-Week
0.9802 +57.11%
on 06/23/23
2.6800 -42.54%
on 01/27/23
-0.6700 (-30.32%)
since 12/01/22

Most Recent Stories

More News
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?

Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.

HROW : 9.31 (+0.87%)
IKNA : 1.5000 (+3.45%)
SRZN : 0.4900 (+2.08%)
IVVD : 1.5400 (+0.65%)
Catalent (CTLT) to Report Q3 Earnings: What's in the Cards?

Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.

CTLT : 40.15 (+3.35%)
IKNA : 1.5000 (+3.45%)
SRZN : 0.4900 (+2.08%)
IVVD : 1.5400 (+0.65%)
Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.

PKI : 115.24 (-0.91%)
IKNA : 1.5000 (+3.45%)
SRZN : 0.4900 (+2.08%)
IVVD : 1.5400 (+0.65%)
After Plunging -26.71% in 4 Weeks, Here's Why the Trend Might Reverse for Invivyd, Inc. (IVVD)

Invivyd, Inc. (IVVD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates...

IVVD : 1.5400 (+0.65%)
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”)...

IVVD : 1.5400 (+0.65%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. - IVVD; ADGI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Invivyd, Inc. (f/k/a Adagio Therapeutics, Inc.) ("Adagio" or the "Company")...

IVVD : 1.5400 (+0.65%)
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Invivyd Investors of a Lead Plaintiff Deadline of April 3, 2023

/PRNewswire/ -- Attention Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. ("Invivyd") (NASDAQ: IVVD) shareholders: The Law Offices of Vincent Wong announce that...

IVVD : 1.5400 (+0.65%)
INVIVYD DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Invivyd, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Invivyd, Inc. (“Invivyd” or the “Company”)...

IVVD : 1.5400 (+0.65%)
INVIVYD 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 3, 2023 to file lead plaintiff applications...

IVVD : 1.5400 (+0.65%)
ADGI : 4.64 (+0.87%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD)

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 3, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Invivyd, Inc....

IVVD : 1.5400 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 1.6700
2nd Resistance Point 1.6200
1st Resistance Point 1.5800
Last Price 1.5400
1st Support Level 1.4900
2nd Support Level 1.4400
3rd Support Level 1.4000

See More

52-Week High 2.6800
Fibonacci 61.8% 2.0307
Fibonacci 50% 1.8301
Fibonacci 38.2% 1.6295
Last Price 1.5400
52-Week Low 0.9802

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar